Autonomix Medical Inc.
AMIX
We are a development-stage medical device company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Our first-in-class technology platform includes a catheter-based microchip-enabled sensing array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
-$12M
▼ -46.5% YoY
Op. Margin
–
ROIC
-154.74%
▼ -82.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$12M
▼ -48.6% YoY
Op. Cash Flow (TTM)
-$12M
▼ -48.7% YoY
Net Debt
-$8M
Net Cash Position
Cash & Equiv.
$8M
Continue Research
Peers
Surgical & Medical Instruments & Apparatus · Pick stocks to compare with AMIX
Autonomix Medical (AMIX) in three numbers
Questions about Autonomix Medical
Is Autonomix Medical (AMIX) overvalued?
Autonomix Medical trades at 0.17 times earnings. Intrinsiqq's fair value calculator has no opening value for AMIX, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.
Is Autonomix Medical a high-quality business?
Autonomix Medical scores 20 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 5 checks computed from SEC filings. Its best check is net debt at -$8M, and its weakest is return on capital at -154.7%. The Quality tab shows every check against its target.
Does Autonomix Medical (AMIX) pay a dividend?
No. Autonomix Medical (AMIX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 6 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in AMIX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing AMIX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.